Fiurox_aerosol_powder
Category
Fiurox_aerosol_powder Brand names, Fiurox_aerosol_powder Analogs
Fiurox_aerosol_powder Brand Names Mixture
No information avaliable
Fiurox_aerosol_powder Chemical_Formula
C8H7N3O5
Fiurox_aerosol_powder RX_link
http://www.rxlist.com/cgi/generic2/furazol.htm
Fiurox_aerosol_powder fda sheet
Fiurox_aerosol_powder msds (material safety sheet)
Fiurox_aerosol_powder Synthesis Reference
No information avaliable
Fiurox_aerosol_powder Molecular Weight
225.158 g/mol
Fiurox_aerosol_powder Melting Point
255 oC
Fiurox_aerosol_powder H2O Solubility
40 mg/L
Fiurox_aerosol_powder State
Solid
Fiurox_aerosol_powder LogP
0.691
Fiurox_aerosol_powder Dosage Forms
Tablets; Liquid
Fiurox_aerosol_powder Indication
For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
Fiurox_aerosol_powder Pharmacology
Furoxone has a broad antibacterial spectrum covering the majority of gastrointestinal tract pathogens including E. coli, staphylococci, Salmonella, Shigella, Proteus, Aerobacter aerogenes, Vibrio cholerae and Giardia lamblia. Its bactericidal activity is based upon its interference with DNA replication and protein production; this antimicrobial action minimizes the development of resistant organisms.
Fiurox_aerosol_powder Absorption
Radiolabeled drug studies indicate that furazolidone is well absorbed following oral administration
Fiurox_aerosol_powder Toxicity
Reactions to Furoxone have been reported including a fall in blood pressure, urticaria, fever, arthralgia, and a vesicular morbilliform rash. Other adverse effects can include a brown discoloration of the urine; hemolysis can occur in G6PDH-deficient patients. The drug has a monoamine oxidase (MAO) inhibitory effect and should never be given concurrently to individuals already taking MAO inhibitors.
Fiurox_aerosol_powder Patient Information
No information avaliable
Fiurox_aerosol_powder Organisms Affected
Microbes (bacteria, parasites)
